RNXT RenovoRx

• $84K bought by 4 insiders
• None no sales outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. Mark Voll CFO
   Buy
   $20K 25,000 shares at $0.7900 +21% to stake
   Traded May 19 Filed May 21
   ↗
3. Laurence Marton Director
   Buy
   — 9,720 shares New stake
   Traded Mar 20 Filed Mar 24
   ↗
4. Shaun Bagai CEO
   Buy
   — 24,300 shares +8.4% to stake
   Traded Mar 20 Filed Mar 24
   ↗
5. Mark Voll CFO
   Buy
   — 97,200 shares New stake
   Traded Mar 20 Filed Mar 24
   ↗
6. Ramtin Agah Chief Medical Officer
   Buy
   $9,975 10,000 shares at $1.00 +1.3% to stake
   Traded Jan 21 Filed Jan 22
   ↗
7. Ramtin Agah Chief Medical Officer
   Buy
   $8,424 9,795 shares at $0.8600 +1.3% to stake
   Traded Dec 31, 2025 Filed Jan 5
   ↗
8. Ramtin Agah Chief Medical Officer
   Buy
   $169 205 shares at $0.8300 +<0.1% to stake
   Traded Dec 30, 2025 Filed Jan 2
   ↗
9. Shaun Bagai CEO
   Buy
   $4,507 5,000 shares at $0.9000 +1.5% to stake
   Traded Dec 18, 2025 Filed Dec 22, 2025
   ↗
10. Shaun Bagai CEO
    Buy
    $4,262 5,000 shares at $0.8500 +1.5% to stake
    Traded Dec 17, 2025 Filed Dec 19, 2025
    ↗
11. Ramtin Agah Chief Medical Officer
    Buy
    $10K 12,000 shares at $0.8500 +1.6% to stake
    Traded Dec 16, 2025 Filed Dec 17, 2025
    ↗
12. Ramtin Agah Chief Medical Officer
    Buy
    $9,600 10,000 shares at $0.9600 +1.3% to stake
    Traded Dec 5, 2025 Filed Dec 8, 2025
    ↗
13. Ramtin Agah Chief Medical Officer
    Buy
    $18K 22,000 shares at $0.8000 +3% to stake
    Traded Nov 21–24 Filed Nov 24, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 3 stock grants.